Fluconazole Dosing for Fungal Infections
Introduction to Fluconazole Treatment
- The American College of Microbiology recommends a loading dose of 800 mg (12 mg/kg) on day 1, followed by 400 mg (6 mg/kg) daily maintenance dosing for systemic candidiasis 1, 2
Systemic Candida Infections
- For systemic candidiasis, the maintenance dose is 400 mg (6 mg/kg) daily 1, 2, 4
- The treatment duration for systemic candidiasis is 2 weeks after first negative blood culture and resolution of symptoms 1, 3
- For candidemia without persistent fungemia or metastatic complications, treat for 2-3 weeks after neutropenia resolution and negative cultures 5, 6
CNS Candidiasis
- The dose for CNS candidiasis is 400-800 mg (6-12 mg/kg) daily for patients unable to tolerate amphotericin B 5, 6, 2
- Treatment should continue until all signs, symptoms, CSF abnormalities, and radiologic findings resolve 5, 6
Urinary Tract Infections
- For symptomatic cystitis, the dose is 200 mg (3 mg/kg) daily for 14 days 5, 6, 2, 4, 3
- For pyelonephritis, the dose is 200-400 mg (3-6 mg/kg) daily for 14 days 5, 6, 2, 4, 3
Pediatric Dosing Conversion
- 3 mg/kg is approximately equivalent to a 100 mg adult dose 2, 3
- 6 mg/kg is approximately equivalent to a 200 mg adult dose 3
- 12 mg/kg is approximately equivalent to a 400 mg adult dose 1
Critical Species-Specific Considerations
- Fluconazole has no activity against Candida krusei and variable activity against C. glabrata—confirm susceptibility before use 2, 4
- For C. parapsilosis, fluconazole is appropriate; if echinocandin used initially, consider switching to fluconazole 6
- For C. glabrata, use echinocandin or amphotericin B initially; only switch to fluconazole if susceptibility confirmed and patient clinically improved 6
- For C. krusei, use echinocandin, amphotericin B, or voriconazole—fluconazole is not effective 6
Common Pitfalls to Avoid
- Inadequate treatment duration can lead to relapse; continue until clinical and laboratory parameters indicate resolution 2
- Resistance development is particularly problematic in patients with recurrent or chronic infections 3
- Neutropenic patients require longer treatment duration (2 weeks after neutropenia resolution) 6